A Study to Compare PK/PD Characteristics and Safety Profiles Between AD-120 and AD-120A

Status:
NOT_YET_RECRUITING

Trial end date:
2025-09-01

Target enrollment:

Participant gender:

Primary endpoint of this study is to evaluate the pharmacokinetic and pharmacodynamic characteristics of AD-120 in healthy subjects.

PHASE1

Addpharma Inc.

Drug Evaluation